biopharmaceutical company
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54), the Patient Protection and Affordable Care Act (P.L. 111-148) and the Food and Drug Administration Safety and Innovation Act (P.L. 112-144). Issues related to health care, the Food and Drug Administration (FDA), oncology coverage and 21st Century Cures. Issues related to Medicare and Medicaid. H.CON.RES.27/S.CON.RES.11, Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. 
FY2016 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations; FDA issues. Issues related to tax reform.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON TODD MATTHEW WEISS MATHEW LAPINSKI ANNE BRADY JAKE PERRY